Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Early diagnosis and multidisciplinary care are crucial for managing CNOT3 syndrome.

GKLF/KLF4 and Sp1 control Keratin 19 gene activity, influencing cancer-related changes.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Reducing miR-30a-5p helps hair follicle stem cells grow and survive.

miR-182 may help treat hallux valgus by targeting FGF9.

Removing the liver tumor improved the patient's skin condition and hair growth.

A rare genetic mutation causes severe immune issues, hair loss, and nail problems.

Clim proteins are essential for maintaining healthy corneas and hair follicles.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

Higher expression of the keratin-associated protein 8.1 gene in Liaoning cashmere goats is linked to finer cashmere fibers.

Researchers found four genes that could help diagnose severe alopecia areata early.

New LSS gene variants help understand congenital hypotrichosis 14 better.

Researchers found a new mutation in the HR gene linked to a rare hair loss condition.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

A specific gene mutation in Japanese people can cause varying degrees of hair thinning in adulthood.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

Gene variation affects prostate issues and hair loss.